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Abstract
The 2010 USDA Dietary Guidelines for Americans (DGA) recommends a diet
largely composed of fruit and vegetables. Consuming a diet high in fruit and
vegetables and low in refined carbohydrates and saturated fat may reduce an
individual’s risk for type 2 diabetes, nonalcoholic fatty liver disease, low-grade
chronic inflammation, and metabolic syndrome (MetS). Several recent studies
have implicated the bioactive sphingolipid ceramide as an associative and cau-
sative biomarker for the development of these conditions. Considering that
the intake of fruit and vegetables is frequently inadequate in young adults, we
performed a pilot investigation to assess the efficacy of a free-living fruit and
vegetable intervention on overall metabolic health, circulating ceramide sup-
ply, and inflammatory status in young adults. We discovered that adoption of
the recommended DGA for fruit and vegetable intake for 8 weeks decreased
waist circumference, systolic blood pressure, and circulating cholesterol. Lipi-
domics analysis revealed that nutritional intervention can lower circulating
ceramides, including C24:0 ceramide, a known inhibitor of insulin signaling.
Unexpectedly, we observed an increase in C16:0 ceramide, suggesting that this
form of ceramide in circulation is not associated with metabolic disease in
humans. We also observed an improved inflammatory status with enhanced
fruit and vegetable intake that was correlated with ceramide concentrations.
These data suggest that adopting the recommended DGA is associated with a
reduction of many, but not all, ceramide species and may help to prevent or
mitigate MetS. Future research needs to assess whether the ceramide-lowering
ability of nutritional intervention is associated with reduced risk of developing
metabolic disease.
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society.
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Introduction
Inadequate intake of fruit and vegetables represents an
unhealthy dietary behavior that results in disproportion-
ally higher rates of obesity-related morbidity and mortal-
ity in young adults residing in the United States (Ford
and Mokdad 2001; Field et al. 2003). Recent evidence
has demonstrated that the inadequate consumption of
fruit and vegetables can predispose individuals to an
increased risk of developing the metabolic syndrome
(MetS), type 2 diabetes mellitus, and cardiovascular dis-
ease (Serdula et al. 1996; Williams et al. 1999; Ford and
Mokdad 2001; Lin and Morrison 2003). This elevated
risk for metabolic disease is alarming if we consider that
78% of young adults consume less than the recommend
amount of fruit and vegetables per day (McCracken
et al. 2007). Epidemiological evidence indicates that the
consumption of a diet enriched with fruit and vegeta-
bles, or one that is low in refined carbohydrates or satu-
rated fats, can improve insulin sensitivity and lower
circulating LDL-cholesterol, and may provide a simple
approach to lower an individual’s risk of developing
chronic metabolic dysfunction (Joshipura et al. 2001;
Wang et al. 2005; Esmaillzadeh et al. 2006; Salas-Salvado
et al. 2011). Given the clear link between inadequate
nutritional intake and obesity-related diseases, evaluating
the effectiveness of dietary interventions to lower meta-
bolic risk factors is necessary.
An important mechanism that regulates the progres-
sion of insulin resistance and related metabolic disor-
ders involves the enhanced synthesis of the bioactive
sphingolipid ceramide. Findings from in vivo investiga-
tions have implicated ceramides in the development of
the MetS in association with diabetic dyslipidemia, hep-
atic lipid deposition, and inflammation, as reviewed by
Holland and Summers (2008). Available evidence sug-
gests that circulating ceramide regulates insulin signaling
by preventing the translocation of glucose transporters
to the plasma membrane through inactivation of PKB
(Boon et al. 2013). In addition to antagonizing insulin
signaling, elevations of lignoceroyl (C24:0) ceramide in
lipoproteins have been demonstrated to increase levels
of the inflammatory cytokine IL-6 and monocyte
chemoattractant protein-1 (MCP-1), and to decrease
anti-inflammatory IL-10 expression in macrophages
(Boon et al. 2013). Lowering ceramide concentrations
by inhibiting synthesis improves insulin resistance,
reduces hepatic lipid accumulation, and reduces inflam-
mation associated with excess energy intake (Bikman
and Summers 2011; Chavez et al. 2014). Based on these
data, ceramides have been recognized as potential
biomarkers for insulin resistance, nonalcoholic fatty
liver disease (NAFLD), and MetS (Lopez et al. 2013;
Meikle et al. 2013), however the potential for dietary
recommendations to lower ceramide levels in humans
has been underexplored.
Diets high in saturated fat increase hepatic ceramide
synthesis and accumulation in rodents with impaired
mitochondrial fatty acid processing and insulin sensitivity
(Summers 2006; Chavez et al. 2014), conditions that often
develop in parallel with NAFLD (Fabbrini et al. 2009).
Specifically, palmitic acid is partitioned away from oxida-
tion and transformed into alternative metabolic fates
including ceramide. Although much of the data demon-
strating the associative or causative relationship between
ceramide and insulin resistance has been derived from
high-saturated fat-feeding studies, Vila et al. (2008) have
established that hepatic ceramides are increased in rats
fed fructose-sweetened water. Vila and coworkers (2008)
propose that the ability of fructose to promote ceramide
synthesis may be attributed to impaired fatty acid b-oxi-
dation. Indeed, diets rich in refined carbohydrates such as
those found in soft drinks can exacerbate NAFLD (Assy
et al. 2008; Asrih and Jornayvaz 2014) and therefore may
potentially increase hepatic ceramide synthesis and
export.
Studies evaluating the efficacy of practical nutritional
interventions to lower circulating ceramide in free-living
subjects are needed. We hypothesize that a dietary inter-
vention focused on increasing the intake of fruit and veg-
etables, and reducing the consumption of refined
carbohydrates or fat in free-living subjects would lower
serum ceramide concentrations in young adults. Our pilot
investigation evaluated individuals that were between 18
and 28 years of age. Although, we employed a lipidomic
approach, we focused our attention on palmitoyl (C16:0)
and C24:0 ceramide because of their associative and cau-
sative role in the development of metabolic disease (Boon
et al. 2013; Hla and Kolesnick 2014; Raichur et al. 2014;
Turpin et al. 2014).
Methods
The West Virginia University Institutional Review Board
approved this research project (Clinical Trial Record
1409433435) that was initiated in January 2015. All par-
ticipants provided written informed consent.
Subject screening
To evaluate eligibility for participation in the study,
young adults in the surrounding area of West Virginia
University (Morgantown, WV) were screened via phone
by a registered dietitian nutritionist (RDN). Subjects were
asked a series of questions in five categories: (1) demo-
graphics (age, willingness to follow nutritional guidelines,
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height, weight, nationality, and pregnancy status), (2)
metabolic risk factors (blood pressure, blood glucose,
body shape (apple, pear, or no distinctive shape), medica-
tions taken, and family history of disease), (3) current
nutritional status (meal frequency, food choices, and level
of alcohol consumption), (4) physical activity level (fre-
quency and type of physically activity), and (5) psycho-
logical and behavioral (satisfaction with weight and body
shape, and assessment of risk for development of an eat-
ing disorder, and smoking/tobacco use). Individuals were
excluded from the study if they were <18 years of age,
pregnant, exhibited an eating disorder, treated for drug or
alcohol abuse within the past year, received psychiatric
treatment within the previous year, had used antibiotics
in the last 3 months, displayed a body mass index (BMI)
of less than 18, or weighed less than 50 kg.
To determine the risk for developing MetS, we devel-
oped a tool (called the Metabolic Syndrome Risk Score)
to categorize individuals into “high”, “medium” or “low”
risk of developing the MetS. The MetS risk score included
the five components of the MetS (waist circumference,
blood pressure, fasting glucose, and circulating triacylglyc-
erol (TAG) and HDL-cholesterol), but also considered
nutritional status, physical activity, ethnicity, family his-
tory, and current medication use.
Intervention design
Following subject screening, thirty-six young adults
(mean = 23.2  2.5 years of age, range = 18–28 years of
age) participated in the 8-week free-living nutritional
intervention using principles of behavior change based
on the Social Cognitive Theory. Although most individu-
als were randomly balanced into three dietary interven-
tion groups, subjects residing together were assigned into
the same dietary intervention to maximize compliance
and minimize difficulties in adherence to the interven-
tion by subjects living in the same household. The diet-
ary interventions were based on the United States
Department of Agriculture (USDA) MyPlate Dietary
Guidelines for Americans (DGA; USDHHS, 2005) and
were defined as follows: 50% of their meal plate must
consist of fruit and vegetables (FRUVED; equivalent to
2.5 or 3 cups of vegetables for women and men, respec-
tively, and 2 cups of fruit daily for all individuals). All
subjects participated in the FRUVED diet, however, this
intervention was divided into three groups: FRUVED
(n = 12), FRUVED plus low refined carbohydrates
(FRUVED + LRC; n = 12), or FRUVED plus low fat
(FRUVED + LF; n = 12). Subjects that were allocated to
the FRUVED + LRC intervention were counseled to con-
sume low-glycemic index foods (e.g., reduced intake of
white bread, crackers, cake, and sugar-sweetened
beverages) and less than 3 oz. of refined carbohydrates,
similar to reported guidelines (USDHHS, 2005). For
FRUVED + LF, subjects were advised to consume a low-
fat diet, as recommended by the American Heart Associ-
ation guidelines (Krauss et al. 2000). Subjects were
instructed to consume 30% or less of caloric intake from
total fat (equally divided into saturated, monounsatu-
rated, and polyunsaturated fat), however the overall mes-
sage conveyed was to choose low-fat, and lean sources of
dairy and protein in accordance with the USDA DGA.
Education and monitoring
Enrolled subjects were required to attend a 2-h group
class (one for each of the different diets) by a RDN just
prior to the start of the intervention. Subjects were pro-
vided instruction in basic nutrition guidelines, nutrition
facts label reading, grocery shopping and budgeting for
fruit and vegetable consumption, resources from local
markets, as well as allowed and prohibited foods for their
intervention. Materials were personalized for each specific
diet to include sample menus and snack suggestions. All
subjects were provided a culinary toolkit to secure success
in fruit and vegetable preparation and planning of meals.
The kit included knives, cutting board, peeler, can opener,
measuring cups for dry and liquid ingredients, and plastic
bags and containers for food storage. With the exception
of diet, subjects were instructed to maintain pre-interven-
tion lifestyle behaviors, including physical activity and
sleep patterns.
On a weekly basis, participants met with the RDN to
be counseled on their intervention plan. The RDN exam-
ined dietary behaviors from weekly participant food logs,
meal photos, and analysis of a 24 h dietary recall using
Nutritionist Pro software (version 1.2, Nutritionist Pro,
San Bruno, CA). By reviewing these measurements
weekly, the RDN was able to counsel subjects on ways to
further adhere to their assigned intervention while ensur-
ing compliance. Apart from these assessments, the RDN
and participant independently rated participant overall
progress and adherence of assigned diet intervention on a
continuum of 1–100 each week. This scale (which consid-
ered physical activity, stress, sleep, and medication use)
was averaged weekly starting at week 2, and used to
determine overall compliance at the end of the study.
Upon completion of the study, if the average was below
90, individuals were excluded from analysis due to non-
compliance to intervention. Monetary incentives were
provided each week (following the completion of sched-
uled visitations with the RDN) to help off-set the poten-
tial and/or perception of greater food expense of
routinely purchasing fresh fruit and vegetables, and to
help with compliance.
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society.
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Blood sampling and anthropometric
measurements
Fasting blood was collected by venipuncture prior to the
intervention, and at week 2, 5, and 8 of intervention. Blood
was allowed to coagulate at room temperature for 30 min
and then centrifuged at 3400g for 10 min at 4°C. Following
centrifugation, serum was decanted and stored at 80°C
until analysis. The West Virginia University, Ruby Memo-
rial Hospital Clinical laboratory provided basic chemistry
analysis (i.e., electrolytes, fasting blood glucose, alkaline
phosphate, aspartate, and alanine aminotransferase (AST
and ALT, respectively)), lipid panel (i.e., TAG, cholesterol,
HDL, LDL, VLDL), and selected endocrine analyses (i.e.,
insulin, high-sensitive C-reactive protein) on blood samples
collected pre (week 0) and post (week 8) intervention.
Weekly physical activity was measured subjectively with
physical activity logs and the International Physical Activity
Questionnaire (IPAQ) pre and postintervention. Physical
activity was also measured objectively with accelerometers
(GT3X; ActiGraph, Pensicola, FL) during the first and last
week. Anthropometric measurements were taken before
and after intervention. Body fat was measured via BodPod
(CosMed USA Inc., Chicago, IL), height by an electronic
Stadiometer (SECA 213), body mass via digital scale (SECA
874), and waist, hip, and neck circumferences measured by
Gulick tape. All measurements were taken twice and aver-
aged by trained study personnel.
Cytokine measurements
Circulating cytokine concentrations were measured from
venous serum samples, using a Mesoscale V-PLEX human
pro-inflammatory panel 1 (#K15049G; MesoScale Diag-
nostics, LLC., Gaithersburg, MD) and chemokine panel 1
(#K15047G) assay kits according to manufacturer proto-
col on a SECTOR Imager 2400 instrument (MesoScale
Diagnostics, LLC.). Each subject’s sample was assayed in
duplicate and then averaged for final analysis. The average
coefficient of variation of the standard curves generated
compared to the expected standard values was less than
10% for all measured cytokines. Minimum detection
levels for cytokines were as follows: IL-6 1.31 pg/mL, IL-
10 0.59 pg/mL, INF-c 4.09 pg/mL, TNF-a 0.87 pg/mL,
MCP-1 0.06 pg/mL, MCP-4 1.51 pg/mL, macrophage-
derived chemokine (MDC) 2.11 pg/mL, thymus- and
activation-regulated chemokine (TARC) 0.14 pg/mL, and
eotaxin 1.70 pg/mL.
Ceramide measurements
Serum ceramide extraction was conducted, using previ-
ously established methods that employ a modified Bligh
and Dyer procedure including C12:0 ceramide as an
internal standard (Avanti Polar Lipids, Alabaster, AL;
Haughey et al. 2004; Rico et al. 2015). The organic layers
from plasma extracts were dried in a nitrogen evaporator
(Organomation Associates Inc., Berlin, MA) and resus-
pended in pure methanol prior to analysis. Ceramides
were detected by multiple reaction monitoring using liq-
uid chromatography coupled with electrospray ionization
tandem mass spectrometry (ESI/MS/MS; API3000; AB
Sciex Inc., Thornhill, ON, Canada) operated in positive
mode. Liquid chromatography and MS/MS parameters
have been previously described (Mielke et al. 2015). Slight
differences in extraction efficiency and fluctuations in
mass spectrometer efficiency were normalized to the
C12:0-ceramide internal standard. Instrument efficiency
was monitored daily and individual plasma extracts were
reanalyzed if the internal standard deviated more than
20% from the overall median internal standard value. The
original or rerun data with internal standard concentra-
tions closest to the median C12:0-ceramide value were
included in the final analysis. Plasma ceramide concentra-
tions were determined by fitting the identified ceramide
species to standard curves based on acyl-chain length.
Ceramide standards were purchased from Sigma-Aldrich
(C16:0, C18:0, and C18:1; St. Louis, MO) or Avanti Polar
Lipids (C20:0, C22:0, C24:0, and C24:1). Glycosylated cer-
amides were purchased from Matreya Inc. (C24:0-GlcCer,
C16:0-LacCer, C18:0-LacCer; Pleasant Gap, PA). Instru-
ment control and quantitation were performed, using
Analyst 1.4.2 and MultiQuant software (AB Sciex Inc.),
respectively.
Statistical analysis
An analysis of variance (ANOVA) was used to examine
difference among the groups. Anthropometric and plasma
data were analyzed as repeated measures over time rela-
tive to start of intervention under the MIXED procedure
of SAS (version 9.3; SAS Institute Inc.). The statistical
model included the random effect of subject, and the
fixed effects of intervention and week relative to start of
intervention, and their interaction. The model included
post hoc adjustment for multiple comparisons, using
Tukey’s adjustment. The method of Kenward–Rogers was
used for calculation of denominator degrees of freedom.
Normality of the residuals was evaluated with normal
probability, box plots, and homogeneity of variances with
plots of residual versus predicted values. When necessary,
data were transformed but presented in the original scale.
When the intervention effect or intervention 9 week
interaction was significant, the SLICE option of SAS was
used to compare intervention differences at individual
time points. Studentized residual values >3.0 or <3.0
2017 | Vol. 5 | Iss. 13 | e13329
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were considered outliers and removed from the analysis
(typically 1 per response variable). Parametric Pearson
correlations were performed in order to determine associ-
ations between plasma ceramides, anthropometric mea-
surements, and circulating cytokines. All results are
expressed as least squares means and their standard
errors, unless stated otherwise. Significance was declared
at P ≤ 0.05, and trends toward significance were consid-
ered at 0.05 <P ≤0.10.
Results and Discussion
The principal finding of our study is that young adults
who are overweight (BMI between 25 and 30) and “at-
risk” of developing MetS show improved metabolic
health following adoption of the USDA recommended
DGA of consuming 50% fruit and vegetables, as evi-
denced by reductions in circulating ceramide, biomarkers
of inflammation, systolic blood pressure, and waist cir-
cumference. It is important to emphasize the current
intervention was a “free-living” study design permitting
subjects to freely choose the type and amount of food
they consumed within their own environment with the
requirement that their meals meet the recommended
50% fruit and vegetable consumption. While this
approach does not control total nutritional intake, the
purpose of this study was not to induce weight loss per
se, but rather determine if adopting the DGA for fruit
and vegetables would produce measureable clinical
changes and/or biomarkers linked with the progression
of cardiometabolic disease.
Although thirty-six subjects participated, six subjects
were not included within our final analyses because the
average weekly compliance score fell below the compli-
ance threshold. Therefore, our data only report the data
from thirty compliant subjects with a mean MetS risk
score of 4.1  0.3 and a mean age of 23.6  0.4
(range = 18 to 28 years of age; 53% female; 66% Cau-
casian; Table 1). The moderate MetS risk score was pri-
marily attributed to subjects being overweight
(BMI = 27.2  5.9; Table 2), as subjects displayed nor-
mal concentrations of circulating fasting triglycerides, glu-
cose and HDL-cholesterol, as well as normal systolic and
diastolic blood pressure (Table 2 and 3). At study, enroll-
ment, demographics, and MetS risk score were compara-
ble for the FRUVED, FRUVED + LRC, and
FRUVED + LF interventions; however, the spread of eth-
nicity was lower in the FRUVED group.
Nutrient intake
Prior to intervention, the subject included in the analysis
consumed less than the recommend 5 cups/d of fruit and
vegetables (by the 2010 USDA DGA; Table 4). Following
the 8-week intervention, all subjects exceeded recommen-
dations by consuming 108% more fruit and vegetables
(P < 0.001), compared to pre-enrollment. Moreover,
intake of total empty calories (defined as calories from
added sugar and added fat by DGA) and fat was reduced
in all subjects by 56% and 8%, respectively (P < 0.05).
Regarding fat intake, the consumption of saturated fat
was reduced by 8.3  1.5 g postintervention (P < 0.05),
Table 1. Metabolic syndrome (MetS) risk score and demographics for compliant intervention subjects.1
All subjects
n = 30
FRUVED
n = 12
FRUVED + LRC
n = 8
FRUVED + LF
n = 10
MetS risk score2 4.1  0.3 4.4  0.5 4.0  0.6 3.8  0.5
Age, years 23.6  0.4 23.7  0.4 22.1  1.2 24.8  0.6
Female 16 (53) 7 (58) 5 (62) 6 (60)
Male 14 (47) 5 (42) 3 (38) 4 (40)
White 20 (66) 10 (83) 3 (38) 7 (70)
African American 2 (7) 0 2 (25) 0
Hispanic 3 (10) 0 2 (25) 1 (10)
Asian 3 (10) 1 (8) 1 (12) 1 (10)
Other 2 (7) 1 (8) 0 1 (10)
Appalachian 18 (80) 9 (75) 4 (50) 5 (50)
Non-Appalachian 12 (40) 3 (25) 4 (50) 5 (50)
1Dietary interventions based on the United States Department of Agriculture MyPlate Dietary Guidelines for Americans included fruit and veg-
etables (FRUVED), FRUVED plus low refined carbohydrates (FRUVED + LRC), or FRUVED plus low fat (FRUVED + LF). Values within parenthesis
represent percent of n.
2Cumulative score determined by the five components of the MetS (waist circumference, blood pressure, fasting glucose, and circulating tria-
cylglycerol and HDL-cholesterol), as well as nutritional status, physical activity, ethnicity, family history, and current medication use. Scores ran-
ged from 1 to 7 on a 12-point scale. Increased scores are indicative of increased risk for developing the MetS.
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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whereas intake of unsaturated fat or cholesterol was not
modified. In contrast, total fiber and sugar intake
increased by 74% and 34%, respectively (P < 0.05).
Specifically, all subjects consumed more insoluble and sol-
uble fiber as well as several sugars including glucose, fruc-
tose, and sucrose, relative to pre-intervention. Only a few
differences in the measured dietary components were seen
among the three dietary arms. Specifically,
FRUVED + LRC consumed less soluble and insoluble
fiber, relative to FRUVED + LF (P < 0.001). Collectively,
the data suggests that the FRUVED + LRC or
FRUVED + LF did not modify intake of refined
carbohydrates or fat, relative to FRUVED. The reason for
no observed differences could be a limitation of using
self-reported measurements of dietary intake or that our
pilot study did not include a nonintervention control
group. Alternatively, consuming more fruit and vegetables
may concomitantly decrease fat and processed carbohy-
drate intake.
Assessment of metabolic health
Although subjects were clinically healthy at the start of
intervention, we observed a significant decrease in waist
Table 2. Anthropometric and blood pressure measurements before and after intervention.1
All subjects (N = 30)
SEM
P-value
Pre Post Group Time Group 9 Time
Weight, kg 77.0 76.0 14.8 0.49 0.07 0.48
BMI, kg/m2 26.4 26.0 4.2 0.33 0.05 0.88
Body fat, % 28.6 25.9 12.5 0.60 0.14 0.37
Waist circumference, cm 83.4 80.6 11.1 0.76 <0.001 0.54
Hip circumference, cm 102.9 102.2 9.3 0.36 0.14 0.36
Neck circumference, cm 36.0 35.6 3.7 0.97 0.01 0.47
Systolic pressure, mm/Hg 118.6 111.8 12.5 0.39 <0.01 0.57
Diastolic pressure, mm/Hg 62.7 60.3 8.3 0.36 0.12 0.76
1Dietary interventions based on the United States Department of Agriculture MyPlate Dietary Guidelines for Americans included fruit and veg-
etables (FRUVED; n = 12), FRUVED plus low refined carbohydrates (FRUVED + LRC; n = 8), or FRUVED plus low fat (FRUVED + LF; n = 10).
Values are presented as least squared means  SEM average of pre (week 0) and post (week 8) intervention.
2Body mass index.
Table 3. Serum metabolic health measurements before and after intervention.1
All subjects (N = 30)
SEM
P-value
Pre Post Group Time Group 9 Time
Glucose, mg/dL 86.9 87.1 8.4 0.29 0.87 0.17
Triglycerides, mg/dL 92.7 87.9 31.2 0.77 0.24 0.23
Cholesterol, mg/dL 181.0 171.7 29.2 0.55 0.05 0.67
HDL-cholesterol, mg/dL 56.6 50.3 11.4 0.96 <0.001 0.50
LDL-cholesterol, mg/dL 105.7 103.7 23.4 0.42 0.66 0.41
VLDL-cholesterol, mg/dL 18.6 17.7 1.2 0.76 0.25 0.21
AST, U/L2 25.4 22.7 2.4 0.42 0.31 0.09
ALT, U/L3 28.7 25.4 5.3 0.31 0.24 0.81
Insulin, lIU/mL 7.0 7.4 3.2 0.18 0.82 0.12
HOMA-IR4 1.5 1.6 0.8 0.10 0.82 0.08
Na, mmol/L 139.1 138.2 2.4 0.30 0.10 0.57
K, mmol/L 3.8 4.0 0.3 0.72 <0.01 0.86
1Dietary interventions based on the United States Department of Agriculture MyPlate Dietary Guidelines for Americans included fruit and veg-
etables (FRUVED; n = 12), FRUVED plus low refined carbohydrates (FRUVED + LRC; n = 8), or FRUVED plus low fat (FRUVED + LF; n = 10).
Values are presented as least squared means  SEM average of pre (week 0) and post (week 8) intervention.
2Aspartate aminotransferase.
3Alanine aminotransferase.
4Homeostasis model assessment-estimated insulin resistance.
2017 | Vol. 5 | Iss. 13 | e13329
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circumference and systolic blood pressure in all subjects
by week 8 (3% and 6%, respectively; P < 0.01; Table 2).
We did not observe changes in body weight, BMI, body
fat %, hip and neck circumference, or diastolic blood pres-
sure following intervention (Table 2). Epidemiological
studies have demonstrated lower BMI with higher fruit
and vegetable intake (Serdula et al. 1996; Williams et al.
1999; Lin and Morrison 2003), however a decrease in adi-
posity is not always associated with this feeding behavior
(Field et al. 2003). Contrasting anthropometric conclu-
sions may be attributed to differences in total energy
intake, duration of behavior, demographics, type of food,
or method of food preparation. Because waist circumfer-
ence and systolic blood pressure are strong risk factors for
the development of MetS, type 2 diabetes and cardiovas-
cular disease (Srinivasan et al. 1996; Wang et al. 2005), we
consider the observed decreases in these measurements to
be favorable intervention outcomes. Comparable to our
anthropometric evaluation, we did not observe changes in
glucose, insulin, estimated insulin sensitivity, LDL-choles-
terol, VLDL-cholesterol, AST, or ALT (Table 3). However,
we did detect lower circulating cholesterol by week 8 (5%;
P = 0.05). In contrast, we observed a significant decrease
in HDL-cholesterol (P < 0.001) postintervention, where
higher levels are associated with atheroprotective
properties (Rader and Hoving 2014) and others have
observed a similar HDL-cholesterol response following a
high fiber intervention (Jenkins et al. 1993). To positively
impact HDL-cholesterol, researchers suggest replacing sat-
urated fat with unsaturated fat instead of decreasing over-
all fat intake (Muller et al. 2003), which was not a
component of our study design.
Previous work has demonstrated an inverse relationship
between the incidence of diabetes and the consumption
of fruit and vegetables (Ford and Mokdad 2001), a
response that may be attributed to increased intake of
dietary fiber, and decreased consumption of fat and
refined carbohydrates as observed in our investigation.
Additionally, our subjects were instructed not to change
physical activity levels during the study in order to pre-
vent confounding beneficial influences that could be con-
ferred by exercise. Given the physical activity levels were
found to not be different between pre versus postmea-
sures in all our subjects, we believe the improved meta-
bolic health was due solely to change in nutrition.
Modifications in circulating ceramides
Current evidence suggests that the development of insulin
resistance, NAFLD, and MetS is intrinsically linked with
Table 4. Daily intervention intake assessment.1
All subjects (N = 30)
SEM
P-value
Pre Post Group Time Group 9 Time
Total calories, Kcal 2263.3 1935.7 498.8 0.96 0.17 0.59
Empty calories, Kcal2 997.6 441.6 594.2 0.54 <0.001 0.87
Fruit and vegetables, cups 2.5 5.2 2.2 0.70 <0.001 0.51
Total carbohydrates, g 228.3 259.6 20.3 0.81 0.17 0.64
Total fiber, g 19.2 34.0 13.9 0.12 <0.001 0.95
Insoluble fiber, g 1.4 3.3 2.3 <0.001 <0.01 0.71
Soluble fiber, g 0.3 0.8 0.5 <0.01 <0.001 0.82
Total sugar, g 78.7 105.4 38.8 0.96 0.03 0.78
Glucose, g 7.8 15.3 1.6 0.24 <0.001 0.31
Fructose, g 8.5 16.8 1.7 0.57 <0.001 0.30
Galactose, g 0.1 1.1 0.3 0.44 0.05 0.96
Sucrose, g 10.1 14.2 2.1 0.13 <0.01 0.79
Lactose, g 6.2 6.3 1.9 0.14 0.31 0.86
Maltose, g 0.5 0.7 0.2 0.23 0.01 0.94
Total protein, g 90.9 91.4 7.9 0.58 0.92 0.39
Total fat, g 90.1 64.7 8.4 0.84 <0.01 0.36
Saturated fat, g 28.8 20.5 17.4 0.60 0.04 0.20
Monounsaturated fat, g 21.0 16.8 17.5 0.59 0.73 0.19
Polyunsaturated fat, g 13.9 10.1 10.9 0.44 0.67 0.60
Cholesterol, mg 227.3 247.4 463.1 0.18 0.98 0.67
1Dietary interventions based on the United States Department of Agriculture MyPlate Dietary Guidelines for Americans included fruit and veg-
etables (FRUVED; n = 12), FRUVED plus low refined carbohydrates (FRUVED + LRC; n = 8), or FRUVED plus low fat (FRUVED + LF; n = 10).
Values are presented as least squared means  SEM average of pre (week 0) and post (week 8) intervention.
2Added calories from fat and sugar.
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the accumulation of ceramide (Holland et al. 2007; Bik-
man and Summers 2011; Brozinick et al. 2012). Increased
caloric intake from saturated fat can activate hepatic cera-
mide synthesis in overweight subjects (Haus et al. 2009;
Holland et al. 2011), and subsequently increase lipopro-
tein ceramide packaging and export (Boon et al. 2013).
In turn, circulating lipoprotein ceramide can mediate
inflammatory cytokine release from adipose tissue macro-
phages, and inhibits insulin-stimulated PKB activation in
skeletal muscle (Boon et al. 2013). These proposed mech-
anisms are consistent with data from several studies that
have reported elevated circulating ceramide in obese ado-
lescents, adults with type 2 diabetes, or rodents with
NAFLD (Haus et al. 2009; Lopez et al. 2013; Kasumov
et al. 2015). Avoiding body weight gain, or consuming
diets low in saturated fatty acids or fructose from non-
fruit sources are a likely means to increase hepatic fatty
acid oxidation, inhibit ceramide synthesis, and lower cir-
culating ceramide to improve metabolic health (Dube
et al. 2011; Dekker et al. 2013). To assess this possibility,
we employed a lipidomic approach to quantify an array
of serum nonglycosylated and glycosylated ceramides in
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young adults consuming a diet enriched with fruit and
vegetables.
The intake of a diet high in fruit and vegetables but
low in refined carbohydrates and fat decreased circulating
total ceramide concentrations by week 5 in young adults
(16% and 48% for FRUVED + LRC and FRUVED + LF,
respectively; P < 0.05; Fig. 1). However, we did not
observe a change in total ceramide levels in the FRUVED
group. Previous research has confirmed that C24:0 cera-
mide is the most abundant ceramide in circulation (Haus
et al. 2009), a subspecies produced by hepatic ceramide
synthase 2 (Laviad et al. 2008) and exported within liver-
derived lipoproteins (Lightle et al. 2003; Boon et al.
2013). Indeed, we observed that C24:0 ceramide was
highly abundant in serum, representing 77% of total cera-
mide at the initiation of intervention (Fig. 2). Relative to
C24:0 ceramide, we detected low circulating levels of
C16:0 ceramide (0.9% of total ceramide) which is synthe-
sized by ceramide synthase 6 (Turpin et al. 2014).
We discovered that the majority of circulating cera-
mides decreased with time for FRUVED + LRC and
FRUVED + LF interventions (Fig. 3); albeit the response
was often greater for FRUVED + LF. For instance, the
concentrations of C22:0, C24:1, and C26:0 ceramide were
significantly lower by week 5 of intervention (29% to
64% for FRUVED + LRC and FRUVED + LF; P < 0.05;
Figs. 3 and 4); ceramide moieties associated with
increased BMI and fasting blood glucose in adolescents
with type 2 diabetes (Lopez et al. 2013). Most notably,
subjects following a diet containing high fruit and veg-
etables with low dietary fat displayed a 50% decrease in
C24:0 ceramide by week 5, relative to the start of inter-
vention (P < 0.01; Fig. 4). We view the lowering of
C24:0 ceramide concentration in serum as a favorable
intervention outcome because lipoprotein C24:0 ceramide
inhibits PKB activation and glucose transporter transloca-
tion in skeletal muscle (Boon et al. 2013), and circulating
C24:0 ceramide is inversely related to insulin-stimulated
glucose disposal in humans (Meikle et al. 2013). High
dietary intake of saturated palmitic acid can increase
C24:0 ceramide accrual (Larsen and Tennagels 2014).
Although we did not detect a change in total or
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saturated fat intake for FRUVED + LF, relative to
FRUVED, the FRUVED + LF group may have exhibited
a lower intake of palmitic acid, a fatty acid required for
de novo ceramide synthesis. Alternatively, hepatic palmi-
tyl-CoA supply may have been limited in these subjects
because of suppressed de novo lipogenesis or enhanced
mitochondrial oxidation. These possibilities may also
explain the ceramide-lowering ability of FRUVED + LRC.
Moreover, differences in circulating and liver fatty acid
pools may explain why FRUVED alone was unable to
lower ceramide.
Although the majority of circulating ceramides declined
following intervention, we did observe an 80%, 70%, and
50% increase in circulating C16:0 ceramide by week 8 for
FRUVED, FRUVED + LRC, and FRUVED + LF, respec-
tively (P < 0.05; Fig. 4). Furthermore, the ratio of C16:0
to C24:0 ceramide increased 66% across time (P < 0.01;
Fig. 5). We and others have previously observed a recip-
rocal relationship between circulating C16:0 and C24:0
ceramide (Raichur et al. 2014; Rico et al. 2017). Research-
ers that have recently evaluated tissue ceramide supply
and insulin action have proposed that C16:0 ceramide is
0 
1000 
2000 
3000 
4000 
5000 
0 2 5 8 
C
16
:0
 c
er
am
id
e 
(n
g/
m
L) Time, P < 0.01 
Diet × Time, P < 0.01 
A
*
0 
1000 
2000 
3000 
0 2 5 8 
C
20
:0
 c
er
am
id
e 
(n
g/
m
L)
Time, P < 0.05 
Diet × Time, P = 0.48 
B
0 
5000 
10,000 
15,000 
20,000 
25,000 
0 2 5 8 
C
22
:0
 c
er
am
id
e 
(n
g/
m
L)
Time, P < 0.01 
Diet  Time, P < 0.05 
C
*
0 
100 
200 
300 
400 
500 
0 2 5 8 
C
22
:1
 c
er
am
id
e 
(n
g/
m
L)
Time, P < 0.01 
Diet × Time, P = 0.12 
D
0 
20,000
40,000
60,000
80,000
100,000
0 2 5 8 
C
24
:0
 c
er
am
id
e 
(n
g/
m
L)
Time, P = 0.19 
Diet  Time, P < 0.01 
E
*
0 
500 
1000 
1500 
2000 
0 2 5 8 
C
24
:1
 c
er
am
id
e 
(n
g/
m
L)
Time, P < 0.01 
Diet  Time, P < 0.05 
F
*
0 
500 
1000 
1500 
2000 
2500 
3000 
0 2 5 8 
C
26
:0
 c
er
am
id
e 
(n
g/
m
L)
Time, P = 0.09 
Diet  Time, P < 0.05 
G
*
FRUVED FRUVED + LRC FRUVED + LF
Week relative to start of intervention
×
×
×
×
Figure 4. Changes in circulating ceramides during intervention. Interventions include FRUVED (50% fruit and vegetable), FRUVED + LRC
(FRUVED plus low refined carbohydrate), and FRUVED + LF (FRUVED plus low fat). Statistical significance compared to FRUVED group within
time point. Statistical significance compared to FRUVED group within time point. *P < 0.05.
2017 | Vol. 5 | Iss. 13 | e13329
Page 10
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society.
Nutritional Intervention Lowers Ceramides A. T. Mathews et al.
a proapoptotic mediator of the pathophysiology of insulin
resistance in response to a high saturated fat diet, and in
contrast, C24:0 ceramide confers antiapoptotic and prolif-
erative functions (Raichur et al. 2014; Turpin et al. 2014).
Nevertheless, our measured increase in serum C16:0 cera-
mide that developed concurrently with lower circulating
cholesterol and reduced waist circumference is a paradox-
ical observation. In support of our findings, Meikle et al.
(2013) did not observe a relationship between circulating
C16:0 ceramide and type 2 diabetes. The ability of C16:0
ceramide to antagonize insulin action may be reliant
upon the intracellular tissue concentration of this sphin-
golipid which was not characterized in our investigation.
Additionally, the ability of extracellular lipoprotein cera-
mide to antagonize insulin signaling may involve a differ-
ent mode of action since long-chain ceramides are highly
hydrophobic and cannot pass freely through the plasma
membrane (Go~ni and Alonso 2006). The relationship
between the acyl chain length of circulating ceramide and
insulin-stimulated glucose disposal requires further inves-
tigation to definitively distinguish C16:0 or C24:0 cera-
mide as the causal agent of insulin resistance in humans.
Modifications in circulating glycosylated
ceramides
We also measured serum GlcCer, a glycosphingolipid
formed via glycosylation of ceramide by the enzyme glu-
cosylceramide synthase. We observed that serum total
GlcCer concentrations were lower for all subjects by week
8 (20%, 32%, and 46% for FRUVED, FRUVED + LRC,
and FRUVED + LF, respectively; P < 0.001; Fig. 1), rela-
tive to start of interventions. Similar to nonglycosylated
ceramides, GlcCer levels are elevated in overweight ani-
mals (Chavez et al. 2014; Rico et al. 2015); however, the
ability of circulating GlcCer to directly antagonize insulin
resistance remains uncertain. To further evaluate gly-
cosphingolipid biology in our subjects, we quantified
serum LacCer that are formed by a (1-4)-b linkage of
galactose to GlcCer. In our investigation, serum total Lac-
Cer levels were not modified by intervention (Fig. 1).
Recent evidence suggests that nonglycosylated ceramides
are stronger circulating biomarkers for diabetes or predia-
betes in adults as compared with GlcCer or LacCer (Mei-
kle et al. 2013). Nevertheless, both nonglycosylated
ceramides and GlcCer have been implicated in the patho-
genesis of insulin resistance at the cellular level (Chavez
et al. 2014).
Specifically, we observed that C24:0 GlcCer and C16:0
LacCer were the most abundant species in each lipid sub-
class (Fig. 2). Moreover, changes in serum GlcCer were
similar to the supply of ceramide (Figs. 3 and 6). Relative
to the start of each intervention, we observed a 31–73%
decrease in serum C22:0, C24:0, and C24:1 GlcCer by
week 5 in FRUVED + LRC and FRUVED + LF subjects
(P < 0.05), respectively. In contrast, intervention did not
modify serum C16:0, C20:0, and C26:1 GlcCer levels. For
LacCer sphingolipids, we detected a decrease in C22:0
and C24:0 LacCer with time (17% and 37% decrease by
week 5; P < 0.01; Figs. 3 and 7); however, we did not
observe changes in the concentrations of serum C16:0,
C24:1, or C26:1 LacCer with intervention. Furthermore,
we observed a strong positive association between C24:0
ceramide and GlcCer, and between C24:0 GlcCer and Lac-
Cer across all sampled subjects (Fig. 8). These results may
indicate a coordinated regulation of synthesis for gly-
cosphingolipids with the C24:0 acyl moiety. Although gly-
cosylated ceramides may mediate the link between obesity
and insulin resistance (Aerts et al. 2007), the causal role
of glycosphingolipids in the progression of insulin resis-
tance is actively being defined. Current evidence suggests
that the insulin receptor is co-localized with glycosphin-
golipids in plasma membrane caveolae (Vainio et al.
2002), and excessive ganglioside content can disrupt insu-
lin signaling by displacing the insulin receptor from these
microdomains (Kabayama et al. 2004). Modifying dietary
energy intake is a likely means to control glycosylated cer-
amide supply. For instance, mice fed a low fat diet exhibit
lower circulating C20:0, C22:0, and C24:0 GlcCer levels as
compared with mice fed a high fat diet (Barber et al.
2012). It is important to recognize that the observed cera-
mide and GlcCer-lowering response associated with
increased fruit and vegetable consumptions developed
even though dietary fructose intake increased. Therefore,
the ability of dietary fructose to augment ceramide syn-
thesis likely depends on compromised hepatic function
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which was not evident in our investigation as demon-
strated by clinically low concentrations of circulating tria-
cylglycerol, VLDL-cholesterol, AST, and ALT, as
supported by Vila and coworkers (2008).
Inflammation and ceramides
Consuming a diet rich in fiber and monounsaturated fat
while reducing intake of saturated fat and cholesterol
can increase fat expenditure and reduce low-grade
chronic inflammation (Esposito et al. 2003), therefore
we assessed the inflammatory status of our subjects.
Although we did not detect changes in circulating
cytokines between our diet intervention groups, our
nutritional intervention did lower circulating MCP-4
and TARC in all subjects by week 8 (P < 0.05; Table 5).
We also observed a tendency for serum anti-inflamma-
tory IL-10 concentration to increase (P = 0.06); however
no changes in IL-6, TNF-a, MCP-1, eotaxin, or INF-c
levels were observed. The ability of fruit and vegetable
intake to suppress inflammation may be due to bioactive
nutrients found in these foods including folate,
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flavonoids, and antioxidants (Watzl et al. 2005; Garcıa-
Lafuente et al. 2009). Specifically, the consumption of
fruit or vegetables, or the intake of vitamin C and b-
carotene is inversely associated with pro-inflammatory
markers in adolescents (Holt et al. 2009).
The ability of inflammation to increase the synthesis of
ceramide has been documented (Holland et al. 2011;
Boon et al. 2013). For instance, saturated fatty acids can
activate proinflammatory receptor toll-like receptor 4
which increases the expression of serine palmitoyltrans-
ferase and ceramide synthase in skeletal muscle, and acti-
vate hepatic sphingomyelinase (Holland et al. 2011). In
our study, multiple ceramides were positively correlated
with pro-inflammatory cytokines (Table 6). For example,
C20:0, C22:0, and C22:1 ceramide were positively associ-
ated with MDC, TARC, TNF-a, and eotaxin (r = 0.33–
0.54; P < 0.05). A similar relationship was observed for a
limited number of GlcCer or LacCer subspecies. Although
the majority of sphingolipids measured were not corre-
lated with INF-c or IL-10, highly abundant C24:0 cera-
mide and GlcCer were significantly correlated with serum
INF-c and IL-10 (r = 0.34 and 0.35; P = 0.05), respec-
tively. Interestingly, the inhibition of ceramide synthesis
can negate the antagonistic effects of inflammation on
insulin sensitivity (Holland et al. 2011), therefore dietary
interventions designed to lower circulating ceramide may
be a means to improve insulin sensitivity in overweight
subjects experiencing inflammation.
Conclusion
In summary, our pilot study demonstrates that an 8-
week free-living fruit and vegetable intervention designed
according to the USDA MyPlate guidelines can lower
waist circumference, reduce systolic blood pressure, and
decrease circulating cholesterol in young adults. More-
over, we establish that a short-term nutritional interven-
tion can lower ceramide, a biomarker for metabolic
disease. Of particular interest, we observed lower levels
of circulating C24:0 ceramide with intervention which is
a known antagonist of insulin action. Although the
majority of ceramides were lowered by the study inter-
vention, we unexpectedly observed an increase in serum
C16:0 ceramide raising the possibility that circulating
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Figure 7. Changes in circulating lactosylceramides (LacCer) during intervention. Interventions include FRUVED (50% fruit and vegetable),
FRUVED + LRC (FRUVED plus low refined carbohydrate), and FRUVED + LF (FRUVED plus low-fat) compared to FRUVED group.
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C16:0 ceramide may not be a causal agent of insulin
resistance in humans. In addition to the changes in cer-
amide supply, a fruit and vegetable intervention lowered
circulating inflammatory cytokines. Collectively, these
data suggest that consuming a healthy diet improves
clinical indices and biomarkers of metabolic and cardio-
vascular health, irrespective of changes in body fat mass.
Future work with a larger sample size is needed to bet-
ter understand the effects of macro or micronutrients on
specific species of ceramides, and the mechanisms by
which these ceramides exert their action, as well as their
etiology in the development of obesity and chronic
diseases such as the MetS, diabetes and cardiovascular
disease.
Table 5. Serum cytokine measurements before and after intervention.1
All subjects (N = 30)
SEM
P-value
Pre Post Group Time Group 9 Time
IL-6 4.1 4.5 0.5 0.59 0.39 0.99
IL-10 2.1 2.4 0.5 0.84 0.06 0.84
IFN-c 23.5 19.7 4.4 0.24 0.84 0.93
TNF-a 10.5 10.3 0.6 0.51 0.19 0.46
MCP-12 245.7 207.2 31.5 0.52 0.26 0.54
MCP-4 152.3 89.7 26.2 0.44 0.02 0.11
MDC3 1299.7 1176.6 139.1 0.38 0.08 0.36
TARC4 222.9 167.0 37.5 0.31 0.04 0.71
Eotaxin 126.6 99.9 18.7 0.86 0.34 0.30
1Dietary interventions based on the United States Department of Agriculture MyPlate Dietary Guidelines for Americans included fruit and veg-
etables (FRUVED; n = 12), FRUVED plus low refined carbohydrates (FRUVED + LRC; n = 8), or FRUVED plus low fat (FRUVED + LF; n = 10).
Values are presented as least squared means  SEM average of pre (week 0) and post (week 8) intervention.
2MCP, monocyte chemoattractant protein.
3MDC, macrophage-derived chemokine.
4TARC, thymus- and activation-regulated chemokine.
Table 6. Correlations between cytokines and ceramides.1
IL-6 IL-10 IFN-c TNF-a MCP-12 MCP-4 MDC3 TARC4 Eotaxin
r P r P r P r P r P r P r P r P r P
Ceramide
C16:0 0.03 0.85 0.03 0.85 0.06 0.73 0.11 0.53 0.05 0.77 0.04 0.83 0.01 0.91 0.08 0.67 0.01 0.93
C20:0 0.29 0.10 0.09 0.62 0.05 0.78 0.33 0.07 0.09 0.61 0.03 0.83 0.36 0.04 0.34 0.05 0.40 0.02
C22:0 0.27 0.13 0.20 0.26 0.17 0.34 0.34 0.06 0.16 0.38 0.07 0.69 0.36 0.04 0.40 0.02 0.42 0.01
C22:1 0.26 0.15 0.14 0.43 0.28 0.13 0.41 0.02 0.02 0.89 0.11 0.55 0.43 0.01 0.51 0.01 0.54 0.01
C24:0 0.21 0.25 0.01 0.97 0.34 0.05 0.29 0.11 0.19 0.31 0.03 0.85 0.29 0.11 0.26 0.15 0.27 0.13
C24:1 0.06 0.72 0.28 0.13 0.08 0.64 0.39 0.02 0.09 0.61 0.22 0.23 0.26 0.16 0.35 0.05 0.36 0.04
GlcCer
C20:0 0.29 0.10 0.27 0.14 0.09 0.62 0.31 0.08 0.15 0.41 0.01 0.94 0.31 0.09 0.29 0.11 0.40 0.02
C22:0 0.27 0.13 0.29 0.11 0.27 0.13 0.27 0.14 0.29 0.11 0.02 0.91 0.26 0.15 0.30 0.09 0.37 0.04
C24:0 0.21 0.25 0.35 0.05 0.28 0.12 0.25 0.16 0.29 0.11 0.01 0.93 0.20 0.28 0.29 0.11 0.36 0.05
LacCer
C22:0 0.32 0.08 0.25 0.18 0.12 0.51 0.29 0.10 0.06 0.72 0.12 0.49 0.34 0.06 0.32 0.07 0.41 0.02
C24:0 0.15 0.40 0.40 0.02 0.01 0.99 0.27 0.14 0.02 0.89 0.05 0.76 0.26 0.15 0.24 0.18 0.32 0.07
1Pearson’s correlation between ceramides and inflammatory cytokines. Data are representative of samples collected at week 0 and 8 relative
to the start of intervention.
2MCP, monocyte chemoattractant protein.
3MDC, macrophage-derived chemokine.
4TARC, thymus- and activation-regulated chemokine.
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